ARCH Venture Partners X LLC insider trades

Open-market stock purchases and sales by ARCH Venture Partners X LLC, 10% Owner at Neumora Therapeutics, Inc, from SEC Form 4 filings since Feb 22, 2019.

Track record: 17% of 6 scored buys are up 5% or more since purchase, averaging -64%.

Recent trades

DateStockTradeValue
Oct 27, 2025NMRA Neumora Therapeutics, IncBought$5M

Companies traded

  • NMRA Neumora Therapeutics, Inc: 3 buys, last Oct 27, 2025
  • PRME Prime Medicine, Inc: 3 buys, last Aug 1, 2025
  • ERAS Erasca, Inc: other filings, last Jul 20, 2021
  • VERV Verve Therapeutics, Inc: other filings, last Jun 21, 2021
  • SNNA Sienna Biopharmaceuticals, Inc: 2 buys, last Feb 22, 2019

Get free alerts when ARCH Venture Partners X LLC files a new trade →